Phase 1 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to understand and follow the study requirements
- People aged 18 or older at the time of screening
- People with a general health and activity level rated as 0 or 1 on a standard oncology scale, meaning they are either fully active or have minor restrictions in physically strenuous activity (confirm with trial site)
- People with confirmed advanced and/or metastatic colorectal cancer, kidney cancer, or pancreatic cancer — or returning serous ovarian cancer that has not responded to platinum-based chemotherapy or where platinum-based chemotherapy is not suitable — where the cancer has progressed or come back after at least one previous course of standard cancer treatment
- People who have provided written consent before any study procedures begin
Who may not be able to join:
- People who are unable to swallow or take oral (by mouth) medications
- People with currently active cancer spread to the brain or the lining around the brain or spinal cord
- People who have had major surgery within 30 days before the first dose of the study drug
- People who are pregnant or currently breastfeeding
- People with a known allergy to any of the inactive ingredients in the study drug
- People with a severe or uncontrolled medical condition that, in the treating doctor's judgment, could put their safety at risk or affect their ability to participate
- People who have taken part in another clinical trial within 4 weeks before the first dose of the study drug
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0048225526724
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Nature, frequency and severity of adverse events (AEs); Occurence of DLTs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.